LivaNova to Explore Strategic Options for Cardiac Rhythm Management Business Franchise

September 14, 2017 by Website Admin in

LivaNova, a market-leading medical technology and innovation company, today announced it is exploring strategic options for its Cardiac Rhythm Management (“CRM”) Business Franchise.

Tweet

Share

Pin it

Previous StoryMoleculin Engages CRO to Begin Clinical Trials of WP1220 for the Treatment of Cutaneous T-Cell Lymphoma Next StoryLivaNova Announces U.S. Launch of Optiflow Arterial Cannulae Family